The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy 2020 | The second COMy meeting of the year: new multiple myeloma data
Saad Usmani, MD, University of North Carolina School of Medicine, Chapel Hill, NC, discusses the successes of the COMy meeting. Since the last virtual meeting in May, there has been new data to highlight and discuss. This interview took place during the Controversies in Multiple Myeloma (COMy) 2020 Virtual World Congress.
Disclosures
Saad Z. Usmani reports consulting for Abbvie, Amgen, BMS, Celgene, GSK, Janssen, Merck, Takeda, Sanofi and SkylineDx; speaker’s fees for Amgen, Celgene, Janssen, Sanofi and Takeda; and research funding from Amgen, Array Biopharma, BMS, Celgene, GSK, Janssen, Merck, Pharmacyclics, Sanofi, Seattle Genetics, SkylineDX, Takeda.
